NatureWise Biotech & Medicals Corporation (TPEX:4732)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
20.90
+1.15 (5.82%)
At close: Feb 11, 2026

TPEX:4732 Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
139.39319.95112.5598.97155.56162.57
Short-Term Investments
438.6294.78362.71344.41292.02259.37
Trading Asset Securities
---50.650.2950.2
Cash & Short-Term Investments
577.99614.73475.26493.98497.87472.13
Cash Growth
17.02%29.35%-3.79%-0.78%5.45%17.19%
Accounts Receivable
45.2456.7355.1764.3565.4860.02
Other Receivables
0.131.611.93--0.05
Receivables
45.3758.3557.164.3565.4860.07
Inventory
83.3984.3782.559.5655.837.71
Prepaid Expenses
12.92--4.15--
Other Current Assets
0.2713.2212.150.234.635.42
Total Current Assets
719.93770.67627.01622.26623.77575.33
Property, Plant & Equipment
5.353.968.623.638.265.33
Goodwill
8.548.548.548.548.548.54
Other Intangible Assets
19.8522.8528.8433.9738.9343.71
Long-Term Deferred Tax Assets
25.6728.4420.1619.1419.418.89
Other Long-Term Assets
7.366.135.285.065.666.44
Total Assets
786.7840.59698.45692.6704.57658.24
Accounts Payable
22.2112.9722.988.822.991.79
Accrued Expenses
16.4313.5415.4322.4130.5335.28
Current Portion of Leases
2.873.354.522.73.942.74
Current Income Taxes Payable
7.418.390.10.681.330.1
Current Unearned Revenue
7.236.515.674.347.497.85
Other Current Liabilities
4.395.685.593.922.092.11
Total Current Liabilities
60.5450.4454.2942.8568.3749.87
Long-Term Leases
1.550.063.27-2.7-
Long-Term Deferred Tax Liabilities
1.972.543.334.245.156.06
Other Long-Term Liabilities
444444
Total Liabilities
68.0657.0364.8951.0980.2259.93
Common Stock
493.77492.9492.9492.9492.9465
Additional Paid-In Capital
193.46193.6577.6770.8469.1369.13
Retained Earnings
26.4555.3364.2978.8163.5765.32
Comprehensive Income & Other
-2.76-0.86-1.29-1.04-1.26-1.14
Total Common Equity
684.48741.02633.56641.51624.35598.31
Minority Interest
34.1742.54----
Shareholders' Equity
718.64783.56633.56641.51624.35598.31
Total Liabilities & Equity
786.7840.59698.45692.6704.57658.24
Total Debt
4.423.47.782.76.642.74
Net Cash (Debt)
573.57611.33467.48491.28491.23469.39
Net Cash Growth
17.44%30.77%-4.84%0.01%4.65%18.51%
Net Cash Per Share
11.6412.279.379.939.969.51
Filing Date Shares Outstanding
4749.2949.249.2949.2949.29
Total Common Shares Outstanding
4749.2949.249.2949.2949.29
Working Capital
659.39720.23572.72579.42555.41525.46
Book Value Per Share
14.5615.0312.8813.0212.6712.14
Tangible Book Value
656.09709.62596.18599576.88546.06
Tangible Book Value Per Share
13.9614.4012.1212.1511.7011.08
Machinery
8.37.77.587.587.617.61
Leasehold Improvements
5.195.195.194.885.085.08
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.